Clinical Nuclear Medicine

Article	Citations
Feasibility and Therapeutic Potential of 177Lu–Fibroblast Activation Protein Inhibitor–46 for Patients With Relapsed or Refractory Cancers	62
Fibroblast Activation Protein Inhibitor PET/CT	61
68Ga-FAPI and 18F-FDG PET/CT Images in a Patient With Extrapulmonary Tuberculosis Mimicking Malignant Tumor	53
Safety of Fibroblast Activation Protein–Targeted Radionuclide Therapy by a Low-Dose Dosimetric Approach Using 177Lu-FAPI04	47
Impact of 18F-FDG PET, PET/CT, and PET/MRI on Staging and Management as an Initial Staging Modality in Breast Cancer	44
Fully Automated Gross Tumor Volume Delineation From PET in Head and Neck Cancer Using Deep Learning Algorithms	43
68Ga-FAPI PET/CT in Assessment of Liver Nodules in a Cirrhotic Patient	40
COVID-19 mRNA Vaccination–Induced Lymphadenopathy Mimics Lymphoma Progression on FDG PET/CT	38
Visualization of Fibroblast Activation After Myocardial Infarction Using 68Ga-FAPI PET	37
68Ga-FAPI-04 Accumulation in Myocardial Infarction in a Patient With Neuroendocrine Carcinoma	37
Tumor Imaging With 68Ga-DOTA-FAPI-04 PET/CT	37
68Ga-FAPI Outperforms 18F-FDG PET/CT in Identifying Bone Metastasis and Peritoneal Carcinomatosis in a Patient With Metastatic Breast Cancer	36
Comparison of 5 Different PET Radiopharmaceuticals for the Detection of Recurrent Medullary Thyroid Carcinoma	35
Decentralized Distributed Multi-institutional PET Image Segmentation Using a Federated Deep Learning Framework	34
Sentinel Node Imaging and Radioguided Surgery in the Era of SPECT/CT and PET/CT	33
Axillary Lymph Nodes Hypermetabolism After BNT162b2 mRNA COVID-19 Vaccination in Cancer Patients Undergoing 18F-FDG PET/CT	32
Increased 68Ga-FAPI Uptake in Chronic Cholecystitis and Degenerative Osteophyte	31
Theranostic Approach in Breast Cancer	30
99mTc-PSMA SPECT/CT Versus 68Ga-PSMA PET/CT in the Evaluation of Metastatic Prostate Cancer	30
Comparison of 68Ga-FAPI and 18F-FDG PET/CT in a Patient With Cholangiocellular Carcinoma	29
177Lu-/68Ga-PSMA Theranostics in Recurrent Glioblastoma Multiforme	29
18F-FDG PET/CT and Serial Chest CT Findings in a COVID-19 Patient With Dynamic Clinical Characteristics in Different Period	28
Two Tumors, One Target	28
Visceral Metastases as Predictors of Response and Survival Outcomes in Patients of Castration-Resistant Prostate Cancer Treated With 177Lu-Labeled Prostate-Specific Membrane Antigen Radioligand Therap	28
Feasibility of Deep Learning-Guided Attenuation and Scatter Correction of Whole-Body 68Ga-PSMA PET Studies in the Image Domain	26

FAPI Uptake in a Vertebral Body Fracture in a Patient With Lung Cancer	26
18F-FDG PET and 18F-FDG PET/CT in Vulvar Cancer	26
The Challenge of Staging Breast Cancer With PET/CT in the Era of COVID Vaccination	24
Prognostic Impact of 18F-FDG PET/CT in Patients With Aggressive B-Cell Lymphoma Treated With Anti-CD19 Chimeric Antigen Receptor T Cells	23
Widespread Metastatic Gastric Signet-Ring Cell Carcinoma Shown by 68Ga-FAPI PET/CT	23
Inflammatory Arthritis Induced by Anti-Programmed Death-1 Shown in 68Ga-FAPI PET/CT in a Patient With Esophageal Carcinoma	23
68Ga-FAPI PET/CT in Thyroid Cancer With Thyroglobulin Elevation and Negative Iodine Scintigraphy	22
68Ga-FAPI PET/CT in Assessment of Leptomeningeal Metastases in a Patient With Lung Adenocarcinoma	22
68Ga-FAPI PET/CT Detects Gastric Signet-Ring Cell Carcinoma in a Patient Previously Treated for Prostate Cancer	22
Elevated 68Ga-FAPI Activity in Splenic Hemangioma and Pneumonia	22
Incidental CT Findings Suspicious for COVID-19–Associated Pneumonia on Nuclear Medicine Examinations	22
Increased FAPI Uptake in Brain Metastasis From Lung Cancer on 68Ga-FAPI PET/CT	21
COVID-19 Vaccination–Associated Lymphadenopathy on FDG PET/CT	20
68Ga-FAPI Uptake of Thyroiditis in a Patient With Breast Cancer	20
Comparison of 68Ga-FAPI and 18F-FDG PET/CT in the Imaging of Pancreatic Cancer With Liver Metastases	20
The Imaging Features and Clinical Associations of a Novel Tau PET Tracer—18F-APN1607 in Alzheimer Disease	20
Assessment of Lesion Detectability in Dynamic Whole-Body PET Imaging Using Compartmental and Patlak Parametric Mapping	20
COVID-19 Vaccination Manifesting as Incidental Lymph Nodal Uptake on 18F-FDG PET/CT	19
68Ga-FAPI PET/CT Versus 68Ga-DOTATATE PET/CT in the Evaluation of a Patient With Neuroendocrine Tumor	19
Increased 68Ga-FAPI-04 Uptake in Schmorl Node in a Patient With Gastric Cancer	19
Novel Experience in Hybrid Tracers	19
Assessment of Central Nervous System Lymphoma Based on CXCR4 Expression In Vivo Using 68Ga-Pentixafor PET/MRI	19
Rosai-Dorfman Disease—Utility of 18F-FDG PET/CT for Initial Evaluation and Follow-up	19
Uterine Uptake of 68Ga-FAPI-04 in Uterine Pathology and Physiology	18
FAP-Targeted Radionuclide Therapy of Advanced Radioiodine-Refractory Differentiated Thyroid Cancer With Multiple Cycles of 177Lu-FAPI-46	18
Fibroblast Activation Protein–Targeted PET Imaging of Metastatic Castration-Resistant Prostate Cancer Compared With 68Ga-PSMA and 18F-FDG PET/CT	18
Elevated 68Ga-FAPI Accumulation in a Recurrent Angiomyolipoma	18
68Ga-FAPI PET/CT Versus 18F-FDG PET/CT for Detecting Metastatic Lesions in a Case of Radioiodine-Refractory Differentiated Thyroid Cancer	17
Oligometastatic Bone Disease in Castration-Sensitive Prostate Cancer Patients Treated With Stereotactic Body Radiotherapy Using 68Ga-PSMA PET/CT	17
Organizing Pneumonia With Intense 68Ga-FAPI Uptake Mimicking Lung Cancer on 68Ga-FAPI PET/CT	17
Head-to-Head Comparison of 18F-DOPA PET/CT and 68Ga-DOTANOC PET/CT in Patients With Midgut Neuroendocrine Tumors	17
The Effect of Various β Values on Image Quality and Semiquantitative Measurements in 68Ga-RM2 and 68Ga-PSMA-11 PET/MRI Images Reconstructed With a Block Sequential Regularized Expectation Maximization	17
18F-FDG PET/CT and 68Ga-FAPI-4 PET/CT Findings of Bilateral Knee Osteoarthritis in a Patient With Uveal Malignant Melanoma	17
Clinical Evaluation of 18F-PI-2620 as a Potent PET Radiotracer Imaging Tau Protein in Alzheimer Disease and Other Neurodegenerative Diseases Compared With 18F-THK-5351	16
Idiopathic Retroperitoneal Fibrosis With Intense Uptake of 68Ga-Fibroblast Activation Protein Inhibitor and 18F-FDG	16
Comparing 99mTc-PSMA to 99mTc-MDP in Prostate Cancer Staging of the Skeletal System	16
Intense Diffuse Uptake of 68Ga-FAPI-04 in the Breasts Found by PET/CT in a Patient With Advanced Nasopharyngeal Carcinoma	16
177Lu-FAPI Therapy in a Patient With End-Stage Metastatic Pancreatic Adenocarcinoma	16
False-Positive 68Ga–Fibroblast Activation Protein-Specific Inhibitor Uptake of Benign Lymphoid Tissue in a Patient With Breast Cancer	16
The American College of Nuclear Medicine Guidance on Operating Procedures for a Nuclear Medicine Facility During COVID-19 Pandemic	16
68Ga-FAPI PET/CT Improves Therapeutic Strategy by Detecting a Second Primary Malignancy in a Patient With Rectal Cancer	16
Peptide Receptor Radionuclide Therapy as First-Line Systemic Treatment in Advanced Inoperable/Metastatic Neuroendocrine Tumors	16
COVID-19 Vaccine–Related Local FDG Uptake	16
The Combined Interpretation of 68Ga-DOTATATE PET/CT and 18F-FDG PET/CT in Metastatic Gastroenteropancreatic Neuroendocrine Tumors	16
Prospective Correlation of Prognostic Immunohistochemical Markers With SUV and ADC Derived From Dedicated Hybrid Breast 18F-FDG PET/MRI in Women With Newly Diagnosed Breast Cancer	15
68Ga-DOTA-FAPI-04 PET/CT in Erdheim-Chester Disease	15
Primary Central Nervous System Lymphoma Revealed by 68Ga-FAPI and 18F-FDG PET/CT	15
Hybrid PET/MRI in Staging Endometrial Cancer	15
18F-PSMA 1007 in Suspected Renal Cell Carcinoma	15
99mTc-MIP-1404 SPECT/CT for Assessment of Whole-Body Tumor Burden and Treatment Response in Patients With Biochemical Recurrence of Prostate Cancer	15

Comparison of 18F-DOPA Versus 68Ga-DOTATOC as Preferred PET Imaging Tracer in Well-Differentiated Neuroendocrine Neoplasms	15
Performance Evaluation of a Deep Learning System for Differential Diagnosis of Lung Cancer With Conventional CT and FDG PET/CT Using Transfer Learning and Metadata	14
Dose Calculations and Dose-Effect Relationships in 177Lu-PSMA I&T Radionuclide Therapy for Metastatic Castration-Resistant Prostate Cancer	14
Clinical Assessment of 177Lu-DOTATATE Quantification by Comparison of SUV-Based Parameters Measured on Both Post-PRRT SPECT/CT and 68Ga-DOTATOC PET/CT in Patients With Neuroendocrine Tumors	14
Impact of 68Ga-FAPI-04 PET/CT on Staging and Therapeutic Management in Patients With Digestive System Tumors	14
Potential and Most Relevant Applications of Total Body PET/CT Imaging	14
Comparison of 18F-FDG, 68Ga-FAPI, and 68Ga-DOTATATE PET/CT in a Patient With Pancreatic Neuroendocrine Tumor	13
Head-to-Head Comparison of the Two MAO-B Radioligands, 18F-THK5351 and 11C-L-Deprenyl, to Visualize Astrogliosis in Patients With Neurological Disorders	13
68Ga-FAPI-04 PET/CT Imaging for Fibrous Dysplasia of the Bone	13
Is It Time to Introduce PET/CT in Colon Cancer Guidelines?	13
Pitfalls in the Detection of Insulinomas With Glucagon-Like Peptide-1 Receptor Imaging	13
Incidental COVID-19 Pneumonia on 18F-Fluorocholine PET/CT	13
18F-FDG–Avid Lymph Nodes After COVID-19 Vaccination on 18F-FDG PET/CT	13
First-in-Human Experience With 177Lu-DOTAGA.(SA.FAPi)2 Therapy in an Uncommon Case of Aggressive Medullary Thyroid Carcinoma Clinically Mimicking as Anaplastic Thyroid Cancer	13
Combined 18F-FDG PET/CT Radiomics and Sarcopenia Score in Predicting Relapse-Free Survival and Overall Survival in Patients With Esophagogastric Cancer	13
Dual-Phase 99mTc-MIBI SPECT/CT in the Characterization of Enhancing Solid Renal Tumors	13
Increased 68Ga-FAPI Uptake in Ankylosing Spondylitis in a Patient With Rectal Cancer	13
Response to Treatment in IgG4-Related Disease Assessed by Quantitative PET/CT Scan	13
18F-THK5351 PET Can Identify Core Lesions in Different Amyotrophic Lateral Sclerosis Phenotypes	12
Comparison of Prostate-Specific Membrane Antigen PET/CT and Contrast-Enhanced Magnetic Resonance Imaging in Follow-up Assessment of Juvenile Nasal Angiofibroma—A Novel Pilot Study	12
Agreement Between 18F-FDG PET/CT and Whole-Body Magnetic Resonance Compared With Skeletal Survey for Initial Staging and Response at End-of-Treatment Evaluation of Patients With Multiple Myeloma	12
225Ac-PSMA-617 Radioligand Posttherapy Imaging in Metastatic Castrate-Resistant Prostate Cancer Patient Using 3 Photopeaks	12
FDG PET/MRI of Acute Myocarditis After mRNA COVID-19 Vaccination	12
The Search for New 2-18F-FDG PET/CT Imaging Biomarkers in Advanced Ovarian Cancer Patients	12
Pearls and Pitfalls in Interpretation of 68Ga-DOTATOC PET Imaging	12
Radiation Recall Pneumonitis on FDG PET/CT Triggered by COVID-19 Vaccination	12
68Ga-DOTATATE and 18F-FDG PET/CT for the Management of Esthesioneuroblastoma of the Sphenoclival Region	12
Incidental Detection of Elastofibroma Dorsi With 68Ga-FAPI-46 and 18F-FDG PET/CT in a Patient With Esophageal Cancer	12
Early 18F-FDG PET Flare-up Phenomenon After CAR T-Cell Therapy in Lymphoma	12
False-Positive Axillary Lymph Nodes on FDG PET/CT Resulting From COVID-19 Immunization	12
FDG PET/CT and MRI Features of Pathologically Proven Schwannomas	11
A Case of Coronavirus Infection Incidentally Found on FDG PET/CT Scan	11
First Clinical Experience With [68Ga]Ga-FAPI-46-PET/CT Versus [18F]F-FDG PET/CT for Nodal Staging in Cervical Cancer	11
Increased 68Ga-FAPI Uptake in Neurofibromatosis in a Patient With Pleomorphic Rhabdomyosarcoma	11
Lymphoscintigraphic Findings as Indicators of Lymphaticovenous Anastomosis Outcome in Patients With Extremity Lymphedema	11
FDG PET Findings Post–COVID Vaccinations	11
Immunoglobulin G4–Related Sclerosing Cholangitis Revealed by 68Ga-FAPI PET/MR	11
68Ga-FAPI and 18F-PET/CT Images in Intestinal Tuberculosis	11
Blood-Pool SPECT/CT in Chronic Ankle Tendinopathy	11
68Ga-Fibroblast Activation Protein Inhibitor, a Promising Radiopharmaceutical in PET/CT to Detect the Primary and Metastatic Lesions of Chromophobe Renal Cell Carcinoma	11
Metabolic Imaging Patterns on 18F-FDG PET in Acute and Subacute LGI1 Autoimmune Limbic Encephalitis	11
Fibrous Dysplasia Mimicking Skeletal Metastasis on 68Ga-FAPI PET Imaging	11
Differentiation of Reactive Lymph Nodes and Tumor Metastatic Lymph Nodes With 68Ga-FAPI PET/CT in a Patient With Squamous Cell Lung Cancer	11
The Role of 68Ga-FAPI PET/CT in Detection of Metastatic Lobular Breast Cancer	11
Prostate-Specific Membrane Antigen Expression in Patients With Differentiated Thyroid Cancer With Thyroglobulin Elevation and Negative Iodine Scintigraphy Using 68Ga-PSMA-HBED-CC PET/CT	10
177Lu-DOTATOC Peptide Receptor Radionuclide Therapy in a Patient With Neuroendocrine Breast Carcinoma and Breast Invasive Ductal Carcinoma	10
Photopenic Defects in Gliomas With Amino-Acid PET and Relative Prognostic Value	10
Fusion 68Ga–Prostate-Specific Membrane Antigen PET/MRI on Postoperative Surveillance of Juvenile Nasal Angiofibroma	10
Response to Concomitant Enzalutamide and 177Lu-PSMA-617 Radioligand Therapy in ATM-Mutated Metastatic Castration Resistant Prostate Cancer	10
Pleural Metastasis of Papillary Thyroid Cancer Depicted by 68Ga-FAPI PET/CT	10
68Ga–Prostate-Specific Membrane Antigen PET/CT Uptake in Intraventricular Meningioma in the Choroid Plexus	10
Similar Findings on 18F-MFBG PET/CT and 68Ga-DOTATATE PET/CT in a Patient With Widespread Metastatic Pheochromocytoma	10
The Concept of Strength Through Synergy Applied to the Search of Powerful Prognostic Biomarkers in Gastroesophageal Cancer	10
Alterations in 18F-FDG PET/MRI and 15O-Water PET Brain Findings in Patients With Neurological Symptoms After COVID-19 Vaccination	10
Peptide Receptor Radionuclide Therapy in Patients With Differentiated Thyroid Cancer	10
Visualization of Motor Cortex Involvement by 18F-THK5351 PET Potentially Strengthens Diagnosis of Amyotrophic Lateral Sclerosis	10
68Ga-DOTA-FAPI-04 PET/CT in Neuroendocrine Carcinoma of the Liver With Elevated AFP Level	10
Increased 68Ga-FAPI Uptake in the Pulmonary Cryptococcus and the Postradiotherapy Inflammation	10
225Ac-DOTATOC–Targeted Somatostatin Receptor α-Therapy in a Patient With Metastatic Neuroendocrine Tumor of the Thymus, Refractory to β-Radiation	10
Feasibility and Therapeutic Potential of Combined Peptide Receptor Radionuclide Therapy With Intensive Chemotherapy for Pediatric Patients With Relapsed or Refractory Metastatic Neuroblastoma	10
Interference of Known or Suspected Endometriosis in Reporting FDG PET/CT Performed in Another Indication	10
JAK Inhibitor Effectiveness in Giant-Cell Arteritis With Large-Vessel Involvement Assessed by 18F-FDG PET-CT	10
Use of 68Ga-FAPI PET/CT for Detecting Myeloid Sarcoma of the Breast and Assessing Early Response to Chemotherapy	10
Imaging of Tumor Hypoxia With 18F-EF5 PET/MRI in Cervical Cancer	10
Feasibility of 177Lu Therapy Monitoring Using Fast Whole-Body SPECT Recordings Provided by a High-Speed 360° CZT Camera	10
Comparative Performance of 99mTc-TRODAT-1 SPECT/CT and 18F-FDOPA PET/CT Imaging in Patients With Parkinson’s Disease, Parkinson-Plus Syndrome, and Essential Tremor	10
68Ga-FAPI-04 PET/CT Versus 18F-FDG PET/CT in Malignant Peritoneal Mesothelioma	10
COVID-19 Pneumonia Mimicking Immunotherapy-Induced Pneumonitis on 18F-FDG PET/CT in a Patient Under Treatment With Nivolumab	10
68Ga-FAPI PET/CT Versus 18F-FDG PET/CT for the Evaluation of Disease Activity in Takayasu Arteritis	10
Dysautonomia Is Linked to Striatal Dopamine Deficits and Regional Cerebral Perfusion in Early Parkinson Disease	10
Vaccine-Related Lymph Nodes	10
Bone Tuberculous Granulomatous Inflammation Mimicking Malignancy on 68Ga-FAPI PET/CT	10
Systemic Vasculitis Following SARS-CoV-2 mRNA Vaccination Demonstrated on FDG PET/CT	10
18F-FDG PET/CT Metabolic Behavior of COVID-19 Pneumonia	10
The Detection Performance of 18F–Prostate-Specific Membrane Antigen-1007 PET/CT in Primary Prostate Cancer	9
68Ga-FAPI Versus 18F-FDG PET/CT in Evaluating Newly Diagnosed Breast Cancer Patients	9
Intense 68Ga-FAPI Uptake in a Patient With Myositis Ossificans	9
PET/CT Integrated With CT Colonography in Preoperative Obstructive Colorectal Cancer by Incomplete Optical Colonoscopy	9
Usefulness of 68Ga-Pentixafor PET/CT on Diagnosis and Management of Cushing Syndrome	9
Histopathological Features of Parathyroid Adenoma and 18F-Choline Uptake in PET/MR of Primary Hyperparathyroidism	9

68Ga-FAPI PET/CT Distinguishes the Reactive Lymph Nodes From Tumor Metastatic Lymph Nodes in a Patient With Nasopharyngeal Carcinoma	9
Solitary Fibrous Tumors of the Pleura Shown on 18F-FDG and 68Ga-DOTA-FAPI-04 PET/CT	9
Prognostic Value of 18F-FDG PET in Neuroendocrine Neoplasm	9
New Biomarkers With Prognostic Impact Based on Multitracer PET/CT Imaging in Neuroendocrine Neoplasms	9
Benign Bone Cyst Mimicking Bone Metastasis Demonstrated on 68Ga-FAPI	9
Uncommon Metastases From Occult Breast Cancer Revealed by 18F-FDG and 68Ga-FAPI PET/CT	9
Prognostic Significance of Pretreatment 18F-FDG PET/CT Volumetric Parameters in Patients With Colorectal Liver Metastasis	9
18F-Fluciclovine PET/CT in Therapeutic Decision Making for Prostate Cancer	9
Chatbots in Medical Research	9
68Ga-FAPI PET/CT Detected Non–PSMA/FDG-Avid Primary Tumor in De Novo Metastatic Prostate Cancer	9
Prostate-Specific Membrane Antigen–Avid Meningioma Detected in 68Ga–Prostate-Specific Membrane Antigen PET/CT	9
Clinical and Striatal Dopamine Transporter Predictors of Mild Behavioral Impairment in Drug-Naive Parkinson Disease	9
The Use of Random Forests to Identify Brain Regions on Amyloid and FDG PET Associated With MoCA Score	9
68Ga-FAPI PET/CT Imaging of Graves Ophthalmopathy in a Patient With Esophageal Cancer	9
68Ga-FAPI-46 PET/CT in a Metastatic Castration-Resistant Prostate Cancer Patient With Low PSMA Expression	9
68Ga-PSMA PET/CT and 18F-FDG PET/CT in Renal Cell Carcinoma	9
Chemokine Receptor 4–Targeted 68Ga-Pentixafor PET/CT in Response Assessment of Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma	9
Bone Uptake in Prostate Cancer Patients	9
Evaluation of the Hybrid Tracer Indocyanine Green–99mTc-Nanocolloid for Sentinel Node Biopsy in Bladder Cancer—A Prospective Pilot Study	9
Sentinel Lymph Node Biopsy in Prostate Cancer Using the SENSEI® Drop-In Gamma Probe	9
68Ga-DOTATOC PET for Treatment Efficacy Evaluation of Cardiac Sarcoidosis	9
225Ac-Prostate-Specific Membrane Antigen Therapy for Castration-Resistant Prostate Cancer	9
Interobserver Agreement Rates on Fibroblast Activation Protein Inhibitor–Directed Molecular Imaging and Therapy	9
Peritoneal Tuberculosis Mimicking Peritoneal Carcinomatosis on 68Ga-FAPI-04 and 18F-FDG PET/CT	8
68Ga-DOTA-FAPI-04 PET/CT Imaging in a Case of SAPHO Syndrome	8
Recurrent Glioma	8
FDG PET/CT in a Patient With Mantle Cell Lymphoma and COVID-19	8
Primary Pancreatic Lymphoma on FDG PET/CT	8
68Ga-PSMA Uptake Patterns of Clear Cell Renal Carcinoma Across Different Histopathological Subtypes	8
Nivolumab-Induced Periaortitis Demonstrated by FDG PET/CT	8
COVID-19 Vaccine–Induced Multisystem Inflammatory Syndrome With Polyserositis Detected by FDG PET/CT	8
Evolving Bilateral Hypermetabolic Axillary Lymphadenopathy on FDG PET/CT Following 2-Dose COVID-19 Vaccination	8
18F-Fluciclovine–Avid Reactive Axillary Lymph Nodes After COVID-19 Vaccination	8
Reliability of Quantitative 18F-FDG PET/CT Imaging Biomarkers for Classifying Early Response to Chemoradiotherapy in Patients With Locally Advanced Non–Small Cell Lung Cancer	8
Lymph Node Assessment in Prostate Cancer	8
Use of 68Ga-FAPI PET/CT for Evaluation of Peritoneal Carcinomatosis Before and After Cytoreductive Surgery	8
Detection of Insulinomas Using Dual-Time-Point 68Ga-DOTA-Exendin 4 PET/CT	8
Is There Any Role for 18F-Fluciclovine PET/CT in the Presence of Undetectable PSA in Prostate Cancer Patients After Definitive Treatment?	8
PET Imaging of Meningioma Using the Novel SSTR-Targeting Peptide 18F-SiTATE	8
89Zr-PSMA-617 PET/CT May Reveal Local Recurrence of Prostate Cancer Unidentified by 68Ga-PSMA-11 PET/CT	8
Comparison of Contrast-Enhanced CT + CT Enterography and 68Ga-DOTANOC PET/CT in Gastroenteropancreatic Neuroendocrine Tumors	8
Distribution Pattern of the Monoamine Oxidase B Ligand, 18F-THK5351, in the Healthy Brain	7
18F-PSMA 1007 Uptake in a Man With Metastatic Breast Cancer	7
Diagnostic Test Accuracy of 18F-FDG PET or PET/CT for Characterization of Histologic Type of Thymic Epithelial Tumor	7
Positron Emission Tomography Imaging of Programmed Death 1 Expression in Cancer Patients Using 124I-Labeled Toripalimab	7
Positive FAPI PET/CT in a Bilateral Mammary Angiosarcoma Patient With Less Impressive FDG PET/CT Images	7
PET Imaging of Dementia	7
Intense 68Ga-FAPI-46 Activity in Lesions of Recurrent Ovarian Clear Cell Carcinoma That Were Negative on FDG PET/CT Study	7
An Intravenous 100-mL Lipid Emulsion Infusion Dramatically Improves Myocardial Glucose Metabolism Extinction in Cardiac FDG PET Clinical Practice	7
Systemic Immune Response Syndrome After COVID-19 Immunization—Initial and Follow-up 18F-FDG PET/CT Imaging Appearances	7
Dermatomyositis on 68Ga-FAPI PET/CT in a Patient With Nasopharyngeal Carcinoma	7
DOTATATE -Avid Bilateral Axilla and Subpectoral Lymphadenopathy Induced From COVID-19 mRNA Vaccination Visualized on PET/CT	7
Utility of PET to Appropriately Select Patients for PSMA-Targeted Theranostics	7
New Horizons in Radioligand Therapy	7
Are We Approaching a Change in Paradigm in PET/CT Imaging of Solid Gastrointestinal (or Digestive) Tract Tumors With the Clinical Application of FAPI Imaging?	7
68Ga-DOTATATE Uptake in Primary Breast Cancer	7
68Ga-PSMA PET/CT With Incidental Finding of COVID-19 in an Asymptomatic Patient	7
18F-MFBG PET/CT Is an Effective Alternative of 68Ga-DOTATATE PET/CT in the Evaluation of Metastatic Pheochromocytoma and Paraganglioma	7
Lipid-Poor Renal Angiomyolipoma Mimicking Renal Cell Carcinoma on 68Ga-FAPI-04 PET/CT	7
Rare Brain Metastasis in Parotid Adenoid Cystic Carcinoma Detected on 68Ga-PSMA PET/CT	7
68Ga–Prostate-Specific Membrane Antigen PET–Positive Paget Bone Disease With Metastatic Prostatic Carcinoma	7
Uncovering an Optic Nerve Sheath Meningioma Using 68Ga-DOTATATE PET/CT	7
Incidental Finding of COVID-19 Lung Infection in 18F-FDG PET/CT	7
Delayed Nephrotoxicity After 225Ac-PSMA-617 Radioligand Therapy	7
Supraclavicular and Axillary Lymphadenopathy Induced by COVID-19 Vaccination on 18F-Fluorthanatrace, 68Ga-DOTATATE, and 18F-Fluciclovine PET/CT	7
COVID-19 Vaccination Manifesting as Unilateral Lymphadenopathies Detected by 18F-Choline PET/CT	7
18F-FDG PET/CT in Hodgkin Lymphoma With Unsuspected COVID-19	7
DOTATATE Uptake in an Axillary Lymph Node After COVID-19 Vaccination	7
68Ga-FAPI PET/CT Imaging of Multiple Muscle Metastases of Pancreatic Cancer	7
Increased 18F-ALF-NOTA-FAPI and 18F-FDG Uptake in Renal Angiomyolipoma	7
18F-FDG PET/CT in Follicular Dendritic Cell Sarcoma With Paraneoplastic Pemphigus as the First Manifestation	7
Effect of Different 131I Dose Strategies for Treatment of Hyperthyroidism on Graves’ Ophthalmopathy	7
Outcome of 177Lu-PSMA Radionuclide Treatment in Advanced Prostate Cancer and Its Association With Clinical Parameters	7
Differences in 18F-FDG Uptake and Expression of Glucose Transporter Between 2 Distinct Subtypes of Mass-Forming Intrahepatic Cholangiocarcinomas	7
A Drop-in Gamma Probe for Minimally Invasive Sentinel Lymph Node Dissection in Prostate Cancer	7
Atypical Presentation of COVID-19 Incidentally Detected at 18F-FDG PET/CT in an Asymptomatic Oncological Patient	7
Esophagitis Mimicking Esophageal Cancer on 68Ga-FAPI PET/CT	7
Quantitative Features From CHO PET Distinguish the WHO Grades of Primary Diffuse Glioma	7
Post Contusion Breast Hematoma Mimicking Malignancy on FDG PET/CT	7
Lesion-Based Radiomics Signature in Pretherapy 18F-FDG PET Predicts Treatment Response to Ibrutinib in Lymphoma	7
Follicular Thyroid Adenoma Showing Avid Uptake on 68Ga-DOTA-FAPI-04 PET/CT	6
68Ga-PSMA-11 and 18F-FDG PET/CT in a Case of Ductal Adenocarcinoma of the Prostate	6
Peptide Receptor Radionuclide Therapy in Patients With Neurofibromatosis Type 2	6
One-by-One Comparison of Lymph Nodes Between 18F-FDG Uptake and Pathological Diagnosis in Esophageal Cancer	6
124I-PET/CT–Guided Diagnosis and Personalized Treatment of Metastatic Papillary Thyroid Cancer to the Pancreas	6
68Ga-DOTATATE PET/CT in Primary Pulmonary Lymphoepithelioma-Like Carcinoma	6
Incidental Detection of Sacral Insufficiency Fracture on 68Ga-FAPI PET/MR	6
68Ga-PSMA PET/CT to Distinguish Brain Metastasis of Renal Cell Carcinoma From Radiation Necrosis After Stereotactic Radiosurgery	6
18F-FDG and 68Ga-FAPI-04 in the Evaluation of Aggressive Perivascular Epithelioid Cell Tumor	6
68Ga-PSMA–Avid Small Cell Lung Cancer on PET/CT	6
The Association of Tumor Burden by 18F-FDG PET/CT and Survival in Vulvar Carcinoma	6
18F-FDG PET/CT Imaging of Testicular Myeloid Sarcoma in a Pediatric Patient	6
Incidental Detection of Sinonasal Inverted Papilloma With 68Ga-FAPI PET/CT in a Patient With Esophageal Cancer	6
Features of Systemic Immune Response From COVID-19 Vaccination on 18F-FDG PET/CT	6
Efficacy and Safety of the 64Cu(II)Cl2 PET/CT for Urological Malignancies	6